A pharmacokinetic and pharmacodynamic study In vivo of human HT29 tumours using 19F and 31P magnetic resonance spectroscopy

This publication has 28 references indexed in Scilit:

• The effect of blood flow modification on intra- and extracellular pH measured by 31P magnetic resonance spectroscopy in murine tumours
  British Journal of Cancer, 1995
• Association of intratumoral pharmacokinetics of fluorouracil with clinical response
  The Lancet, 1994
• Preclinical and clinical aspects of biomodulation of 5-fluorouracil
  Cancer Treatment Reviews, 1994
• The non-invasive monitoring of low dose, infusional 5-fluorouracil and its modulation by interferon-α using in vivo 19F magnetic resonance spectroscopy in patients with colorectal cancer: A pilot study
  Annals of Oncology, 1993
• Thymidine-modulated 5-fluorouracil metabolism in liver and RIF-1 tumors studied by 19F magnetic resonance spectroscopy
  Magnetic Resonance Imaging, 1992
• Enhanced 5-fluorouracil cytotoxicity and elevated 5-fluoronucleotides in the rat Walker carcinosarcoma following methotrexate pre-treatment: a 19F-MRS study in vivo
  British Journal of Cancer, 1992
• Detection of differential sensitivity to 5‐fluorouracil in ehrlich ascites tumour cells by ¹⁹F NMR spectroscopy
  NMR in Biomedicine, 1991
• In vivo monitoring of changes in 5-fluorouracil metabolism induced by methotrexate measured by19F NMR spectroscopy
  Magnetic Resonance in Medicine, 1991
• Prediction of 5-fluorouracil cytotoxicity towards the Walker carcinosarcoma using peak integrals of fluoronucleotides measured by MRS in vivo
  British Journal of Cancer, 1989
• 5-Flourouracil metabolism monitored in vivo by 19F NMR
  British Journal of Cancer, 1984